HoloAsh is Selected for the Accenture HealthTech Innovation Challenge

Regional Event in Tokyo

San Francisco, CA, October 24, 2018 --(PR.com)-- HoloAsh has been selected from 1,117 highquality
startup applications to participate in the regional Accenture HealthTech Innovation Challenge being held
November 1, 2018 in Tokyo.

About HoloAsh (https://holoash.com)

Yoshua CEO has ADHD and he thinks we humans need to create a social system in which differences
can thrive.

HoloAsh is creating a virtual assistant for adults with ADHD (ADD). Based on Cognitive Science and the
NLP technique, HoloAsh will help ADHD people get organized.

Actually there are 10M diagnosed adults with ADHD and estimate another 10M who have disorder but
are undiagnosed. It's becoming huge problem. (https://www.additudemag.com/the-statistics-of-adhd/)

According Yoshua CEO, "The Brain is very plastic. People who use smartphones everyday become
distracted and discouraged by notifications or SNS. This is similar to ADHD."

HoloAsh is now are creating a therapy chatbot, but will connect to hardware based on cognitive science to
improve the UX for the future.

About Accenture HealthTech Innovation Challenge in Tokyo

Now in its third year, the Accenture HealthTech Innovation Challenge brings together leadingedge
startups with prominent life sciences companies and healthcare organizations to tackle the world's biggest
health challenges, including access, quality and affordabilityofcare options.

The HealthTech Innovation Challenge is part of Accenture's broader HealthTech Innovation program
which also includes acceleration and venture opportunities, innovation labs, and more.

To learn more about it, or to book an interview, contact Yoshua Kishi at email, yoshua@holoash.com

HoloAsh, Inc.
Creating a virtual assistant for getting organized for Adult ADHD.
President and CEO: Yoshua Kishi

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
HoloAsh, Inc.
Yoshua Kishi
905-415-2188
Contact via Email
https://holoash.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/768187

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use